Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
With oral GLP-1 formulations entering the market and a broader pipeline of next-generation agents on the horizon, benefit leaders now need a second layer of analysis: how today's trajectory informs spend projections as the product landscape expands
Dr
kidney problems - swelling, urinating less, feeling tired or short of breath
Potential drug interactions Sermorelin has no known major drug interactions, but may have the following interactions with certain drugs: Glucocorticoids (prednisone) May blunt growth hormone (GH) release Oral estrogens May increase IGF-1 resistance Insulin or sulfonylureas May alter glycemic control Somatostatin analogs May antagonize Sermorelins effects Dopamine antagonists May disrupt human growth hormone (HGH) regulation GABAergic meds May reduce pulsatility of HGH release Beta blockers (Metoprolol or Propranolol) Other secretagogues/peptides May result in unsafe levels of HGH Other important safety information Sermorelin is only for patients who are at least 30 years old
J., Erb, D
263,272 Considerations in women Women of reproductive age taking a GLP-1 receptor agonist or tirzepatide should be advised to use contraception concurrently due to potential safety concerns associated with taking these pharmacotherapies in pregnancy (as shown in animal studies)
